DANIEL ZURR
Biocon, Quark get DCGI nod for trials of new eye disease drugBiocon Chairperson Kiran Mazumdar Shaw said, "India has a significant number of NAION patients and we are pleased to be the first one to pr...
Biocon inks licensing pact with US-based Quark PharmaBiocon today said it has inked a pact with Quark Pharmaceuticals, Inc to develop a range of siRNA (small interfering RNA) based novel thera...
- Load More